Health
Tocilizumab, Rheumatoid Arthritis Medication, Found to Reduce Severe COVID-19 Deaths – Science Times
Clinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to…
India, one of the most ethnically diverse countries, conducted the first randomized trials on the use of rheumatoid arthritis medication, Tocilizumab, to reduce death risks in severe COVID-19 cases.
Headed by researchers from the University of Bristol and Medanta Institute of Education and Research, they explained that data gathered from clinical trials add to existing evidence that supports the use of Tocilizumab, an anti-inflammatory drug, in critically ill patients.
Science Behind Tocilizumab…
-
Business22 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General23 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News9 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General22 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts